Publication | Open Access

Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial

Advanced Lung DiseaseClinical TrialsTezepelumab Versus PlaceboPulmonary MedicinePharmacotherapyMedicinePulmonary Disease